Roswell Park - UPCI Ovarian Cancer SPORE Clinical Trials
Available Clinical Trials
SPORE Project 4
Novel Risk Factors and Potential Early Detection Markers for Ovarian Cancer
Cancer Immunotherapy Trials Network
A Pilot Study of the Immunological Effects of Neo-Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
Checkpoint Inhibitors
A Phase 1 Study to Evaluate the Safety and Tolerability of Anti-PD-L1, MEDI4736, in Combination with Tremelimumab in Subjects With Advanced Solid Tumors
Upcoming Clinical Trials
- A Phase I/IIa Open Label Clinical Trial Evaluating the Safety and Efficacy of Adoptive Transfer of NY-ESO-1 TCR Engineered Autologous T Cells in Combination with Decitabine in Patients with Recurrent or Treatment Refractory
- A Phase I study of MHC-restricted and MHC-non-restricted targeting of ovarian cancer by αDC1-induced CTLs
View a list of all SPOREs provided by the Translational Research Program at the National Cancer Institute.